FUJI; Masahiro

Patent Applications and Registrations

Patent applications and USPTO patent grants for FUJI; Masahiro.The latest application filed is for "antiviral agent".

Company Profile

0.8.6

FUJI; Masahiro - Osaka JP
Fuji; Masahiro - Osaka-shi JP
Fuji, Masahiro - Shiojirish-Nagano JP
Fuji, Masahiro - Osaka-shi Osaka-fu JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antiviral Agent App 20170066754 - KIYAMA; Ryuichi ; et al.	2017-03-09
Antiviral agent Grant 9,572,813 - Kiyama , et al. February 21, 2	2017-02-21
Antiviral Agent App 20150202208 - KIYAMA; Ryuichi ; et al.	2015-07-23
Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase Grant 7,759,372 - Fuji , et al. July 20, 2	2010-07-20
Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase App 20060293334 - Fuji; Masahiro ; et al.	2006-12-28
Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity Grant 7,148,237 - Fuji , et al. December 12, 2	2006-12-12
Heat-generating element, heat-generating substrates, heat-generating substrate manufacturing method, microswitch, and flow sensor App 20040256376 - Arakawa, Katsuji ; et al.	2004-12-23
Antiviral agent App 20040229909 - Kiyama, Ryuichi ; et al.	2004-11-18
Pyrrolotriazine derivatives having spla2-inhibitory activities Grant 6,787,545 - Ohtani , et al. September 7, 2	2004-09-07
Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity App 20040127708 - Fuji, Masahiro ; et al.	2004-07-01
Tricyclic azaindolizine derivatives having an sPLA2-inhibitory activities Grant 6,756,376 - Fuji , et al. June 29, 2	2004-06-29
Tricyclic compounds having sPLA2-inhibitory activities Grant 6,703,385 - Ohtani , et al. March 9, 2	2004-03-09
Tricyclic compounds having sPLA2-inhibitory activities Grant 6,673,781 - Ohtani , et al. January 6, 2	2004-01-06
Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect Grant 6,472,389 - Ohtani , et al. October 29, 2	2002-10-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.